Advances in pain management for older adult patients

被引:16
作者
Abrahm, JL [1 ]
机构
[1] Univ Penn, Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/S0749-0690(05)70057-4
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Management of pain is crucial to the success of any program of care and support for dying patients and their families. Pain can be controlled in more than 90% of older adults. Components of an effective program include comprehensive, repeated pain assessment; detection and treatment of complicating medical and psychological disorders (e.g., delirium); spiritual concerns; and the judicious use of nonpharmacologic and pharmacologic therapies, radiation, and radiopharmaceuticals. Strategies that enable clinicians to prevent and treat the expected complications of nonsteroidal anti-inflammatory and opioid therapies are reviewed. Strategies to change opioid agents or routes to minimize opioid-induced side effects and to provide effective pain relief as death nears are presented.
引用
收藏
页码:269 / +
页数:44
相关论文
共 121 条
[1]  
Adami S, 1997, CANCER, V80, P1674, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1674::AID-CNCR18>3.3.CO
[2]  
2-D
[3]   Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life [J].
Ahmedzai, S ;
Brooks, D .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 13 (05) :254-261
[4]  
Albert M S, 1992, J Geriatr Psychiatry Neurol, V5, P14
[5]  
[Anonymous], 1998, J Am Geriatr Soc, V46, P635
[6]  
[Anonymous], 1997, J AM GERIATR SOC, V45, P1273
[7]  
[Anonymous], 1994, Catechism of the Catholic Church
[8]  
[Anonymous], 1996, CANC PAIN REL GUID O
[9]   Opioid substitution to reduce adverse effects in cancer pain management [J].
Ashby, MA ;
Martin, P ;
Jackson, KA .
MEDICAL JOURNAL OF AUSTRALIA, 1999, 170 (02) :68-71
[10]   Comparative efficacy and safety of controlled-release morphine suppositories and tablets in cancer pain [J].
Babul, N ;
Provencher, L ;
Laberge, F ;
Harsanyi, Z ;
Moulin, D .
JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 38 (01) :74-81